Report of the Committee on Therapeutic Procedures for Acute Infectious Diseases and on Biologicals of the American Academy of Pediatrics

PEDIATRICS ◽  
1948 ◽  
Vol 1 (2) ◽  
pp. 301-301

A complete revision with a new chapter on Quarantine and Isolation. Chapter 2 on Chemotherapy and Chapter 3 on Antibiotic Agents have been extensively revised. An authoritative statement of the most recent and acceptable information.

PEDIATRICS ◽  
1996 ◽  
Vol 98 (6) ◽  
pp. 1225-1226
Author(s):  
PETER L. HURST

Plotkin's informative commentary entitled "Varicella Vaccine" cites reservations of "many American pediatricians" as reason for the vaccine's low acceptance. From a public health perspective, I question whether use of a vaccine ought to be determined by individual physicians instead of groups of experts like the Committee on Infectious Diseases of the American Academy of Pediatrics. I also wonder whether the reluctance to endorse the vaccine is not related to its cost. An informal survey disclosed a range of $60 to $100 per immunization.


PEDIATRICS ◽  
1961 ◽  
Vol 28 (3) ◽  
pp. 515-515
Author(s):  

The dosage of gamma-globulin recommended for adults for the prevention of hepatitis with jaundice in the 1961 edition of the "Redbook" of the American Academy of Pediatrics has been questioned by Drs. Gellis and McComb in the preceding communication. The Committee on Control of Infectious Diseases, which is charged with the revision of the "Redbook," realizes that the optimum dose of gamma-globulin for adults is not known. Although there is good evidence based on well-controlled studies that 0.01 ml/lb is effective in preventing jaundice in children, comparable evidence is lacking for adults.


PEDIATRICS ◽  
1956 ◽  
Vol 17 (1) ◽  
pp. 162-165
Author(s):  
HAROLD K. FABEER ◽  
R. CANNON ELEY ◽  
RALPH V. PLATOU

In its report of October 4, 1955, the Committee on the Control of Infectious Diseases of the American Academy of Pediatrics, in somewhat guarded and carefully couched terms, approved the resumption of vaccination against poliomyelitis (Pediatrics, 16: 737, 1955). This report was accepted by the Executive Board and was presented to the general session of the Academy on the morning of October 5, without any opportunity for dissident opinions to be expressed or debated. A good many physicians, particularly those who have closely followed recent developments, we believe, still have misgivings over the safety of the vaccine which have not been wholly allayed by the Committee's statement.


Sign in / Sign up

Export Citation Format

Share Document